Skip to main content
. 2021 Sep;42(5):417–424. doi: 10.2500/aap.2021.42.210058

Figure 3.

Figure 3.

Effect of individual biologics on antibiotic courses for AECRS. (A) Mepolizumab reduced antibiotics in total CRS and CRSsNP but not CRSwNP, (B) benralizumab reduced antibiotics in total CRS and CRSsNP but not CRSwNP, (C) omalizumab reduced antibiotics in total CRS and CRSsNP but not CRSwNP, and (D) dupilumab reduced antibiotics in total CRS and CRSwNP but not CRSsNP. Statistical significance was determined by using the two-tailed test with p < 0.05. AECRS = Acute exacerbation of chronic rhinosinusitis; CRS = chronic rhinosinusitis; CRSsNP = chronic rhinosinusitis without nasal polyps; CRSwNP = chronic rhinosinusitis with nasal polyps.